How to Navigate the Increasingly Stormy Waters of Accessing US Managed Markets
The US reimbursement landscape for prescription drugs has been shifting rapidly over the last few years. Some of the major US access trends that have accelerated include: As part of our continuous engagement with market stakeholders, Certara invited 31 managed care organization (MCO) leaders – all active voting members of Pharmacy & Therapeutics committees in … Continued